The new show at Lacoste/Keane Gallery in Concord, MA features both painting and ceramics—a new approach for the gallery in that it combines both the fine art of painting with (what is sometimes considered) the “lowly” craft of ceramics–and establishes a dialogue between the forms.

The show, entitled “Tim Rowan: Presence: Unifying Presence of Sculpture and Painting” features sculptures by Rowan, a leading ceramic artist in the Northeast, and abstract paintings by internationally-known Bernd Haussman,  whose works were  selected to compliment Rowan’s’ work.

The exhibit, at 25 Main Street in Concord, MA, runs through Dec. 1.

Tim Rowan
According to a gallery press release, “The ceramics elements of the show take visitors into the experience of an object’s presence and show how, by contemplating the materials and processes, the artist becomes ‘present’ with the work.

“Also, this significant new body of work by Rowan uses darker clay body with a darker firing— reflecting on how he sees our turbulent time.

“Among the upright vessels and boxes, a group of the intriguing elliptic forms (see Untitled Vessel VIII, below, left) resemble a capsule, missile or rocket mimicking a futuristic machine.

“The sense of irony is not lost to the artist as he examines the notion of man-made versus technology made works,” the writeup continues.  “What has been a study of technological forms like cogs and turbine in Rowan’s early works has evolved into abstract concepts.

“In Untitled Vessel X with Silver Tips (pictured below, right) a sleek dark grey hollow egg form with silver luster glaze conveys this and the artist’s energy.”

Shown in the gallery since 2000, Rowans work has taken a new direction, according to Gallery co-owner LaiSun Keane.

“In the past, it was the glorification of machine and this show is the critique of it – how one finds meaning in everyday life through man-made works and finding the energy of these objects as they are given in the making process.”

Bernd Haussman

Haussman’s paintings, chosen specifically by Keane and her co-owner Lucy Lacoste to compliment Rowan’s ceramic pieces, are, by and large,  two dimensional.

But, like ceramics, some are highly textured , with clay-like or even “fired” surfaces. Their colors and shapes coordinate with those of nearby ceramic pieces—and establish a dialogue with them.

Also like the ceramic pieces, the paintings show the artist’s process–and express the energy that goes into creating them.

As Haussman explained at the show’s opening on Saturday, November 10, many of his paintings express relationships–establishing dialogues– of colors, shapes and ideas– within themselves.

As artist-in residence at the Board Institute of Harvard and MIT from 2012-2015, Haussmann engaged scientists in a non-verbal dialogue through artistic work called “Dialogues.” He also participates in transatlantic exhibitions such as “KunstTraject langs de Leie”, Belgium, and “Art in Embassies.

Born in Tuebingen, Germany, Haussman has lived in the USA since 1994.

In my own view, the provocative ceramic works and beautifully crafted paintings amount to more than the sum of their parts. The novel combination—or dialogue– of objects and paintings makes a statement on the relationship of fine art to crafts–and to artistic creativity. And it turns the Lacoste Keane exhibition space into a work of art in itself.

At Lacoste/Keane Gallery 25 Main Street • Concord, MA 01742 978.369.0278 • www.lacostekeane.com* through December 1, 2018.

–Anita M. Harris

Anita Harris is a writer and communications consultant based in Cambridge, MA. 
New Cambridge Observer is a publication of the Harris Communications Group, also of Cambridge. 

Lacoste Gallery was founded 28 years ago by Lucy Lacoste with a focus on ceramics. In May, 2018, Lacoste joined forces with LaiSun Keane to form Lacoste/Keane Gallery– marking a new chapter in this gallery’s life. This gallery remains deeply committed to clay as an art medium focusing on showing contemporary, post WWII ceramic artists both established and emerging. In conjunction with its main ceramic shows, the gallery will present a 2-D art focus several times a year to broaden the dialogue between its ceramic works and audience. the gallery also offers for sale functional ceramic works by many well-known potters.

I was horrified by the mass shooting in Pittsburgh’s Tree of Life Synagogue…all the more so against a backdrop of  the current climate of hate in the US.

But I was heartened at the showing of support from the individuals, religious people and politicians who attended or spoke at yesterday’s vigil for the shooting victims, held at the bandshell on the Boston Common.

While, of course, the same sort of thing could happen here–and it did, at the 2013 Boston Marathon–I found solace, for a time, in the eloquence and dedication to human rights–especially of Attorney General Maura Healey, Congressman Joe Kennedy, and State Treasurer Deb Goldberg–and of BU student  Ariel Stein, a Boston University student who has belonged all her life to the Tree of Life Synagogue, where the deadly shootings took place. “It is up to all of us to love,” she said.

I’m sorry to have missed talks by Boston Mayor Marty Walsh and Governor Charlie Baker but as one who is generally skeptical about politicians, I felt very glad to live in a state and city that elects responsible leaders–even if I sometimes don’t agree with them.

(I’ve been sending letters and will canvas to encourage infrequent voters to vote in the mid-term elections–and hope that you will do the same.)

Here’s a link to a video of the entire vigil posted on You-Tube  by Combined Jewish Philanthropies.  

–Anita M. Harris
Anita Harris is a writer and communications consultant based in Cambridge, MA. New Cambridge Observer is a publication of the Harris Communications Group, a content, PR and digital marketing agency, also in Cambridge.

It’s not too late to see the work of three influential women i from three generations of ceramicists–Karen Karnes (1925-2016) , Nina Hole (1941-2016), and Ani Kasten (1976…) –at Concord’s Lacoste-Keane Gallery. But hurry, because the show closes September 1.

Karen Karnes, was an American pioneer in ceramics from the generation that came of age after WWII. Part of two legendary art communities: Black Mountain College and the Gatehill Community in New York with Merce Cunningham, John Cage and Robert Rauschenberg among others, Ms. Karnes was a modernist at heart- her inspiration came from Bauhaus. Her work has always been sculptural–even in her functional work. In the 1980’s and 90’s Karnes created her legendary winged vessels and slit forms. In the 2000’s when strength was an issue she turned to her sculptures of combined forms which can be seen as landscape, figurative or still life. Her work is sought after and collected by individuals and museums. Karen Karnes long illustrious career touched and influenced many within her field.

Nina Hole was a Danish ceramic artist well known for her large exterior “Fire Sculptures”. She traveled extensively around the world making her outdoor fire sculptures in situ with a team of assistants and volunteers. One can find her 25 large scale sculptures in countries like Australia, Japan, Denmark, Germany, Mexico, Turkey, Brazil and America. Architecture was a huge inspiration and in addition to making her fire sculptures; she made smaller scale sculptures inspired by houses, churches and buildings. Many who knew her intimately opined on how she really loved the firing processes as they allowed her to work with others. More than just an artist, she was also a huge champion of ceramics through her initiatives Clay Today, The International Ceramic Research Center Guldagergaard and CLAY–Museum of Ceramic Art.

Ani Kasten is an independent ceramic artist whose knowledge came outside the norms of ceramics. She had never touched clay before apprenticing to Rupert Spira in the UK. From England she went to Nepal where she spent four years as head of a project for developing a stoneware ceramic production facility for artisan potters.

Coming back to the US she rehabbed two houses and a studio living complex over the next 10 years all the while making her distinctive ceramics combining stoneware and porcelain with unorthodox and repurposed materials. Similar to Karnes, Kasten’s ceramic foray started in studio pottery which evolved and grew to expressive sculptures for which she is known today. Often Kasten responds to current social and political climate by reflecting them in her works.

This show brings together these influential artists from three distinct generations through their interpretation of ceramic sculpture. Each offers ways of seeing the world through their innovative and artistic expression. All are highly individualistic and mold breaking in their own rights.

“We are thrilled to represent these three legendary ceramic artists and bring their work to the public.” , said  Lucy Lacoste, the gallery’s founder.

Lacoste /Keane Gallery have been appointed the sole representative of Nina Hole’s estate in the USA.
The gallery is wheelchair accessible and free to the public.

Note: Lacoste Gallery is now Lacoste / Keane Gallery with Lucy Lacoste and LaiSun Keane as owners/directors.

The show runs through September 1, 2018.

The gallery is located at 25 MAIN STREET CONCORD, MASSACHUSETTS 01742 T: 978-369-0278 F: 978-369-3375 E: INFO@LACOSTEGALLERY.COM

–Anita M. Harris

I recently interviewed Bob Langer–MIT biotech guru extraordinaire–on behalf of the EBD Group, which holds international partnering conferences for the life sciences six times a year.  Here’s the opening…and a link to the rest, on the EBD Site. The piece will also  appear in xconomy shortly. Full disclosure…Bob is a personal friend, former classmate, and a member of the Harris Communications Group advisory board…so this should be considered a sponsored post.

–Anita M. Harris

When Bob Langer joined the MIT faculty in 1977 he had a rocky start. Trained as a chemical engineer and working on drug delivery systems, many of his ideas went against conventional wisdom. “I had people write the most insulting things about my knowledge of biology and medicine. Many thought my ideas were crazy. A number of professors wanted me to leave and my first nine grant proposals were turned down.”

Eventually, after numerous academic scientists and companies repeated and used his work Langer was able to get grant funding from the NIH. He also turned to companies for research funding—in return for licensing his patents—which, at that time, also went against the conventional grain.

Today, Langer is one of 13 Institute Professors (being an Institute Professor is MIT’s highest honor) at Massachusetts Institute of Technology. With more than 1,400 articles to his credit, he is the ninth most cited individual in history, according to Google scholar. (Sigmund Freud is first). His 1,300 patents, licensed or sublicensed to more than 350 companies in pharmaceutical, chemical, biotechnology and medical device fields, have led to more than 100 products currently in use or in clinical trials. He has received more than 220 major professional awards including the Queen Elizabeth Prize for Engineering, Priestly Medal, National Medal of Science, National Medal of Technology and Innovation, the Charles Stark Draper Prize (considered the equivalent of the Nobel Prize for engineers), and the Lemelson-MIT prize for being “one of history’s most prolific inventors in medicine.” In June 2018, he was named a US international envoy for science by the US State Department.

Despite his success, Langer remains well aware of his early setbacks, and, as a scientific advisor to some 200 companies over the past 40 years, is highly cognizant of what can go wrong.

“You can have bad animal results, failed trials, or patent problems. I’ve seen partners pull out, companies take bad loans, and the FDA create delays. Stumbling blocks can arise anywhere along the way,” he says.

One of the most difficult problems can occur early on “when a researcher has good findings but is not far enough along for investors or companies to want to spend a lot of money.” In that situation, known as “the valley of death,” Langer says, “the question is how to get enough data so that will change.”

More: 

Anita M. Harris is a writer and communications consultant based in Cambridge, MA.

New Cambridge Observer is a publication of the Harris Communications Group, also in Cambridge.

Spent an interesting Wednesday afternoon, last week,  visiting exhibitors at the Bio-IT World Conference & Expo –several of whom won “Best of Show” Awards later that day.

The judges, listed below,  named winners in six categories: Data Integration & Management; Analysis & Data Computing; Genomic Data Services; Data Visualization & Exploration; Storage Infrastructure & Hardware; and the Judges’ Prize.  Attendees also voted on the People’s Choice Award, selecting products that they believed measurably improve workflow or capacity, enabling better research.

One of my favorites was Nanome, which won best in show for Data Visualization and Exploration.
Nanome uses virtual reality to improve the drug discovery process, according to its award application. The company offers applications for experimentation, collaborattion, and learning at the nano-scale– leveraging  VR hardware such as the Oculus Rift and HTC Vive to create immersive virtual workspaces allowing users to visualize, design, and simulate molecules, proteins, and more.

At  Nanom’se i BIO–IT World booth, Marketing Director Jarrell James handed me a pair of VR goggles and two joysticks (?) with which  I could explore within a molecule–by seeming to make components larger, smaller or revolve.

A more sophisticated user might be able to:

• -Import molecular structures from a local machine or an online database such as RCSB or DrugBank.
• – Manipulate molecular structures by literally grabbing, rotating, or enlarging the area of interest with their hands.
• – Apply different representations to their selection of Atoms, Residues, Chains, or Proteins such as Stick, Wire, Ball & Stick, or Van der Waals.
• – Measure distances and angles between atoms.
• – Mutate amino acids and cycle through rotamer libraries.
• – Design small molecules by building with any element from the periodic table.
• – Minimize manipulated molecules to prevent clashes and provide a local energy minimum conformation.
• – Duplicate or Split any selected area of your structure to modify or export independently.
• – Export your molecular structures to PDB.
• – Join a virtual reality session as a guest with or without virtual reality hardware.

• – Present and collaborate in the same virtual environment with colleagues to demonstrate proposals or compare before and after results.

Nanome plans next to enter the education space. The company’s VR technology wil help high school and college students , likely already proficient in gaming technology,  better understqand biologic processes, James said.

The Hyve 

I also spent some time with the folks at Hyve…whose fake robot ( that is, a “robot inhabited” by a human) did make me  curious about Hyve’s work.

RADAR-base
radar-cns.org

As described in the company’s award submission,  the company’s RADAR-base, developed in the framework of the IMI RADAR-CNS project, is an open source platform designed to securely collect, store and share readings from wearable devices and smartphone sensors to enable remote monitoring. The RADAR-base platform consists of three major categories of components:

• Data ingestion: Recognizing and registering data-sources (including smartphones and wearable devices), collecting the data via a direct Bluetooth connection or through a 3rd party API and streaming in near real time to the server (green box in the figure). Using Apache Kafka, the collected data is streamed to dedicated topics in real-time where the data is optimally schematized using Apache Avro;
• Data storage and management: Consists of two centralized storage systems behind an authorized security layer. A cold-storage based on HDFS that is scalable and fault-tolerant focusing on storing large volumes of high frequency raw-data, and a hot-storage based on MongoDB storing aggregated data to provide a near real-time overview of the raw-data. (blue box in the figure);
• Data sharing: Visualizing aggregated data in a live dashboard and exporting raw data for further analyses in various formats including AVRO, JSON and CSV (yellow box in the figure).

The platform is highly secured by a centralized management system of users and their authorities, participants, allowed devices and their specifications. RADAR-Base platform is distributed as Docker containers with associated scripts and configuration files to enable easy installation.

 In addition, I  visited Sinequa, which took the prize in the Analysis & Data Computing category. 

Sinequa ES v10
sinequa.com

The Sinequa Cognitive Search and Analytics platform handles all structured and unstructured data sources and uses Natural Language Processing (NLP), statistical analysis and Machine Learning (ML) in order to create an enriched “Logical Data Warehouse” (LDW). This LDW is optimized for performance in delivering rapid responses to users’ information needs. Users can ask questions in their native language or ask that relevant information be “pushed” to them in a timely fashion when it emerges.

More than 180 connectors ready for use “out of the box” make the process of connecting multiple data sources fast and seamless. Company and industry-specific dictionaries and ontologies can be easily integrated, putting specific knowledge “under the hood” of the Sinequa platform, making it an intelligent partner for anyone in search of relevant subject information.

Other awards, as descrbed in company literature: :

Genomic Data Services

Diploid
Moon 1.0
diploid.com/moon

Moon is the first software to autonomously diagnose rare diseases from WES/WGS data. By applying AI to the domain of rare disease diagnostics, Moon brings speed and scalability to the genome interpretation process.

The software only requires the patient’s gender, age of onset and his/her symptoms – in addition to the genetic data. Moon then goes from whole genome variant data (VCF) to pinpointing the causal variant in less than 5 minutes.

The software highlights one or a few variants that could explain the patient’s phenotype. For every variant, Moon displays an extensive list of annotations that it mined from the literature, allowing geneticists to easily verify decisions from the AI algorithms. Moon’s speed does not only save a lot of time and money, it also saves lives: Moon has already proven its utility in the NICU at Rady Children’s Hospital (San Diego): https://goo.gl/7TDrQD.

Unfortunately, about 50% of rare disease patients remain undiagnosed, even after whole genome sequencing and expert interpretation. Most hospitals don’t have the resources to keep analyzing negative cases even though new correlations between genes and disorders are published every day. Moon changes all this: as the software autonomously mines the literature and analyses samples, it can reanalyze older, negative cases in the background. Only when new information that might lead to a diagnosis becomes available, the assigned geneticist is notified. That way, hospitals can frequently reanalyze thousands of cases with minimal labor, providing a perspective to undiagnosed patients.

Storage Infrastructure & Hardware

PetaGene
PetaSuite Cloud Edition – Version 1.2
petagene.com

Launching at Bio-IT World 2018, PetaSuite Cloud Edition (CE) combines two innovations: (i) the ability for a user’s software tools and pipelines to seamlessly integrate with a wide variety of cloud platforms without modification, and (ii) significantly improved, high-performance, scalable PetaSuite genomic compression technology. 

For example, users can now directly run, without modification, their custom BWA-mem, GATK, Python, Java, shell scripts, and other POSIX-based software/pipelines streaming directly to/from AWS, Google Cloud, Azure, and private cloud storage, as though they were local filestores. PetaSuite CE supports each platform’s object encryption during transfer and at rest. User applications can connect to multiple cloud platforms, buckets and regions as desired, transparently, and on demand, in user-mode, without needing to modify their pipelines, setup mounts, or have administrator privileges.

Whether running on bare-metal, in VMs, or within Docker containers, for public, private or hybrid cloud, PetaSuite CE enables organizations to unlock the power of distributed object storage seamlessly from their POSIX-compliant tools and pipelines.

PetaSuite CE is built from the ground-up for the extremely high performance streaming and random-access workloads demanded by genomics applications. The integrated, transparent PetaGene compression has been significantly improved to deliver even faster compression and greater reductions of up to 6x of both BAM and FASTQ.GZ files, enabling large costs savings in cloud storage and data transfer times. Moreover, PetaGene compression can also preserve the MD5 checksum of the original BAM or FASTQ.GZ file and not just the internal raw SAM/FASTQ data.

The Judges’ Prize went to 

 Linguamatics and its iScite 2.0 (iscite.com) provide a Software-as-a-Service search application that puts the power of text analytics directly into scientists’ hands, according to the company writeup.

Using Linguamatics’ Award-winning Natural Language Processing
Researchers can extract and analyze relevant data to rapidly answer business-critical questions. iScite utilizes Linguamatics’ award-winning Natural Language  L(NLP) based blend of analytical methods. By understanding the semantics and structure of text, iScite handles the variety of ways people express the same information, ensuring searches are comprehensive and accurate.

Easy to use on any device
iScite’s intuitive HTML interface includes a simple search box and auto-complete suggestions. The innovative answer-routing engine lets users answer simple or complex questions using puzzle-piece building blocks – simplifying access to powerful queries that extract concepts, relationships, numerical data such as drug dosages, mutations and more.

Get answers to questions, not just documents
Data sources include Linguamatics’ cloud-hosted content. MEDLINE, Clinical Trials.gov, FDA Drug Labels, PubMed Central, and Patent Abstracts are annotated with curated terminologies for diseases, drugs, genes and organizations. Scientists can answer questions such as:

• What genes are involved in breast cancer?
• What protocol designs have been used for immuno-oncology trials?
• What are the adverse events for kinase inhibitors?

Actionable results
Results are presented in structured form, with bar chart facets for dynamic, visual results-filtering, a document viewer that highlights key terms and relationships, and relevant link-outs. Users can curate, save, and export their results.

iScite allows users across drug discovery and development to cut through the vast information landscape and discover the most valuable insights.

The People’s Choice award went to 

OnRamp BioInformatics, Inc. and itsROSALIND™ platform:  the first-ever genomics analysis platform specifically designed for life science researchers to  analyze and interpret datasets, while freeing up more time for bioinformaticians.

Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, OnRamp’s ROSALIND platform aims to simplify the practice of genomic data interpretation. According to the company’s writeup,  ROSALIND puts the researcher into the driver’s seat of data analysis and democratizes bioinformatics by broadly expanding access to genomic and proteomic technologies for cancer research, precision medicine and sustainable agriculture.

While many open-source tools remain the lifeline of genomic analysis, a simplified and innovative user experience for the biologist can empower them to run their own analyses, while utilizing these tools without the need for typing any command-line instructions.

ROSALIND is powered in partnership with Google Cloud and features scalable compute power and economical cloud-based storage. ROSALIND is a swarming docker-based genomic analysis solution incorporating the industry’s most trusted open-source tools and algorithms, with an angular front-end and secure RESTful API. ROSALIND is also deployable on-premise.

On Ramp technololgists believe that empowering biologists with “an intuitive and comprehensive platform” to explore their data and collaborate with colleagues and bioinformaticians, they  can help accelerate their industry and the widespread adoption of genomic technologies by dramatically lowering costs, reducing  complexity and, ultimately, focus more on what what to do with results, rather than on how to get to them.

In the words of Allison Profitt, BIO-IT World’s editor,” The awards program recognizes the best of the innovative product solutions for the life sciences industry on display at the conference,

“It’s always a treat to explore what’s new in our industry.

” The innovation on display by Bio-IT World exhibitors never disappoints, and we are excited to shine a spotlight on the best life sciences has to offer.”

Judges
“The Best of Show program relies on a panel of expert judges from academia and industry who screen eligible new products and hear presentations from a list of finalists on site. This year our judges considered 46 new products and viewed presentations on site from 18 finalists.”

The 2018 judging panel included Joe Cerro, BostonCIO; Chris Dwan, Bridgeplate; Richard Holland, New Forest Ventures; Eleanor Howe, Diamond Age Data Science; Phillips Kuhl, Cambridge Healthtech Institute; Steve Marshall, Marshall Data Solutions; Michael Miller, Genentech; Art Morales, Analgesic Solutions; Nanguneri Nirmala, Tufts University School of Medicine; Alexander Sherman, Massachusetts General Hospital; Subi Subramanian, Vertex Pharmaceuticals; Bill Van Etten, BioTeam; and Proffitt.

–Anita M. Harris
Anita Harris is a science writer based in Cambridge, MA. 
New Cambridge Observer is a publication of the Harris Commmunications Group, also in Cambridge, ma.  

http://www.lacostegallery.com/

At the opening, Jeff Shapiro described his latest approaches.. After nine years in Japan, where he focused on wood-firing techniques and the “character of clay,” he moved to New York’s Hudson Valley, where for 30 years, he has created sculpture that may have “a sensibility to certain qualities of the Japanese aesthetic,. yet is a departure from both traditional Japanese pots.”  He thinks of his latest work as fine art:  that is, sculpture using clay as his medium.  One new series includes a solid-vertical form in black with a rough textured surface. In some cases, he treats the material like stone, waiting until the clay hardens so that he can carve and chisel it to expose its “inner quality.”  

deconstructed vessels; structural “cuboids; ”  and highly textured slabs which are fired in an electric kiln.

This is Shapiro’s fourth solo show at the Lacoste. It runs through May 26.

Links to
Part I Overview, Watson, analytics
Part II digital devices, long term care.
Part III Apps, devices, roadblocks

Behavioral and Population Health; Roadblocks to change

Can mobile apps really improve mental health? Cut the costs of health care? Help professionals track and care for patients? At a day-long conference sponsored  on health systems innovation organized the MIT/Sloan MIT  Initiative for Health Systems Innovation (HSI), experts from a variety of fields attempted to answer those and other questions aimed at furthering a transformation of  the US healthcare system.  Part III of a series about the conference describes apps and devices for behavioral health, personalized and long-distance care. It also discusses new state models to integrate community, health and social systems aimed at tracking and caring for patients and points out that no matter how sophisticated the technology, it is still up to human beings to make it work.

Behavioral Health

Don Mordecai, Kaiser Permanente

Dan Mordecai, MD, National Leader, Mental Health and Wellness at the managed care consortium Kaiser Permanente described:

• Promising mobile apps aimed at helping people prevent or overcome eating disorders, addiction, or suicide; remain on diets or exercise plans; or connect them with treating providers or coaches.
• Wearables that can measure how much people move or perform text and voice analysis to help professionals understand who needs care, months or years before it is needed.
• Predictive analytics to help prevent self-harm

While many of the above technologies have yet to be proven effective, Mordecai said, telehealth technology has been shown to be helpful in supporting and promoting long-distance health care for areas with shortages of medical personnel.  Telehealth may be carried out through videoconferencing, store-and-forward imaging, streaming media, and terrestrial and wireless communication.  

Mordecai also pointed out that with digital advances, “we are moving from individual doctor patient relationships” to a “personalized’” system, which relies increasingly on data, but that “there is a long way to go.”    Mordecai plans to use what he termed “crowd sourcing” to analyze the effectiveness of apps and other new health technologies, based on the electronic health records of Kaiser Permanente’s   nearly 12 million patients.

State models and population health
Analysis like that used at Kaiser Permanente is crucial for assessing treatment and cutting costs, but it is more challenging to perform outside of managed care programs, which have access to a vast array of patient records, according to Michael Wilkening, the California Undersecretary for Health and Human Services.  Analysis to records for care funded by government or private insurance is hampered by fragmented  social, health provider and  insurance systems and by legal and technical challenges of sharing patient data among those systems,

The New York State Medicaid director, Jason Helgerson, pointed out that for state Medicaid systems,  which serve mainly low-income populations,  it can be difficult to simply keep track of patients,  much less co-ordinate and evaluate their care or reduce their treatment costs.  As an example, he described a city homeless shelter that serves breakfast and dinner, but not lunch. Hungry residents regularly go to the fire station next door and complain of chest pain; they are taken by ambulance to a hospital emergency room, where they are evaluated, at high cost, given lunch, and then transported back to the homeless shelter in time for dinner.

Medicaid systems in at least several states are working on projects to prevent such situations by better integrating social services with medical and behavioral health care. Some are starting to employ analytics to recommend, monitor and measure the success of treatments, and to pay for performance rather than service.  As a result, Helgerson said, “Medicaid may be in the best position to drive change” in health delivery systems.

Roadblocks to change
Still, as a variety of speakers pointed out, despite the promise of digital innovation, there are many roadblocks to change.   Such roadblocks include: reluctance to replace or augment human decision-making with digital solutions;  complex reimbursement systems  and the need for insurer “buy-in” to pay for new technologies;  disparate stakeholders with different goals;  issues of privacy and security;   the  tendency of legislators and other policymakers to view health problems as individual rather than societal;   failure to address the lack of food and shelter that leads to poor health and expensive repeat hospital visits;  and, last but not least, cost.

In the words of Vocera’s Elizabeth Boehm, regarding systemic change, “it takes more than technology to get it done.“

And, as Restef Levi, of the Sloan School, put it: “Technology is important but…at the end of the day, health is about humans.”

LINKS TO:

Part I Overview, Watson, analytics
Part II digital devices, long term care.
Part III Apps, devices, roadblocks

Videotapes and photos of the conference, held November 29, 2017, are available at http://mitsloan.mit.edu/alumni/events/2017-cambridge-health-conference/

–Anita M. Harris

Anita Harris is a writer and communications consultant specializing in health science and technology.

New Cambridge Observer is a publication of the Harris Communications Group, a content and digital marketing firm based in Cambridge, MA.

Ever wonder why people collect art?

You can find out at “Through the Eyes of a Collector,” an exhibit  opening Saturday, Feb. 3, 2018 and running through Feb. 28 at the Lacoste Gallery, in Concord, Ma.

AshwiniBhat Matrikas

The exhibit offers an insight into the art collecting practices of Steve Alpert, an avid ceramic art lover and collector for more than 40 years, according to  the Lacoste invitation.  Alpert has served on the board  of MFA Boston, as Board Chairman of the Institute for Contemporary Art, and was  founder and Chairman of Rose Art Museum at Brandeis University.

In this show, he  brings together a diverse group of artists whose work ranges from studio pottery to figurative and sculptural ceramic art.

 Gaden of Eartlhy DelightsThe artists include:Michael Ashley, Ashwini Bhat, Rick Hirsch, Jeff Kell, Eva Kwong, KyungMin Park and Jack Thompson.

The show, which runs through February 28,  represents Alpert’s vision.  Its goal is to inform new generations of ceramic art fans and collectors on how to begin an astute ceramic art portfolio.

Opening Reception with Artists: Saturday, February 3, 3:00 – 5:00 PM
Panel Discussion: Ceramic Collecting for the New Generation,   Sunday February 4, 2:00 PM 

The exhibit, opening reception and panel discussion are free and open to the public but kindly RSVP for the panel discussion.

LACOSTE GALLERY
25 Main Street Concord,
MA 01742 978-369-0278
Email: info@lacostegallery.com
Web: www.lacostegallery.com 

–Anita Harris

Anita M.Harris is a writer, photographer, communications consultant and art lover based in Cambridge, MA.
New Cambridge Observer is a publication of the Harris Communications Group, a PR and content marketing firm, also in Cambridge.